gian paolo tonini
gian paolo tonini
Neuroblastoma Laboratory, Pediatric Research Institute, Padova, Italy
Adresă de e-mail confirmată pe irpcds.org
Citat de
Citat de
Identification of ALK as a major familial neuroblastoma predisposition gene
YP Mossé, M Laudenslager, L Longo, KA Cole, A Wood, EF Attiyeh, ...
Nature 455 (7215), 930-935, 2008
Dissecting the genomic complexity underlying medulloblastoma
DTW Jones, N Jäger, M Kool, T Zichner, B Hutter, M Sultan, YJ Cho, ...
Nature 488 (7409), 100-105, 2012
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
W Zhang, Y Yu, F Hertwig, J Thierry-Mieg, W Zhang, D Thierry-Mieg, ...
Genome biology 16 (1), 1-12, 2015
Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients
I Casciano, K Mazzocco, L Boni, G Pagnan, B Banelli, G Allemanni, ...
Cell Death & Differentiation 9 (3), 246-251, 2002
Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients
L Passoni, L Longo, P Collini, AML Coluccia, F Bozzi, M Podda, ...
Cancer research 69 (18), 7338-7346, 2009
Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group …
B De Bernardi, B Nicolas, L Boni, P Indolfi, M Carli, ...
Journal of clinical oncology 21 (8), 1592-1601, 2003
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
J Vermeulen, K De Preter, A Naranjo, L Vercruysse, N Van Roy, ...
The lancet oncology 10 (7), 663-671, 2009
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
G Schleiermacher, V Mosseri, WB London, JM Maris, GM Brodeur, ...
British journal of cancer 107 (8), 1418-1422, 2012
Retrospective study of childhood ganglioneuroma
B De Bernardi, C Gambini, R Haupt, C Granata, A Rizzo, M Conte, ...
Journal of Clinical Oncology 26 (10), 1710-1716, 2008
Quality assessment of genetic markers used for therapy stratification
IM Ambros, J Benard, M Boavida, N Bown, H Caron, V Combaret, ...
Journal of clinical oncology 21 (11), 2077-2084, 2003
Prognostic impact of gene expression–based classification for neuroblastoma
A Oberthuer, B Hero, F Berthold, D Juraeva, A Faldum, Y Kahlert, ...
Journal of Clinical Oncology 28 (21), 3506-3515, 2010
MYCN On cogene Amplification in Neuroblastom a Is Associated VVith VVorse Prognosis, Except in Stage 4s: The Italian Experience VVith 295 Children
GP Tonini, L Boni, A Pession, D Rogers
Journal of clinical oncology 15 (1), 85-93, 1997
Transcribed-ultra conserved region expression is associated with outcome in high-risk neuroblastoma
P Scaruffi, S Stigliani, S Moretti, S Coco, C De Vecchi, F Valdora, ...
BMC cancer 9, 1-9, 2009
Neuroblastoma (Peripheral neuroblastic tumours)
R Luksch, MR Castellani, P Collini, B De Bernardi, M Conte, C Gambini, ...
Critical reviews in oncology/hematology 107, 163-181, 2016
Neuroblastoma treatment in the post-genomic era
MR Esposito, S Aveic, A Seydel, GP Tonini
Journal of biomedical science 24 (1), 1-16, 2017
Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on …
M Capasso, SJ Diskin, F Totaro, L Longo, MD Mariano, R Russo, ...
Carcinogenesis 34 (3), 605-611, 2013
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a …
G Schleiermacher, J Michon, A Ribeiro, G Pierron, V Mosseri, H Rubie, ...
British journal of cancer 105 (12), 1940-1948, 2011
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression
VA Lasorsa, D Formicola, P Pignataro, F Cimmino, FM Calabrese, J Mora, ...
Oncotarget 7 (16), 21840, 2016
p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation
A Borriello, VD Pietra, M Criscuolo, A Oliva, GP Tonini, A Iolascon, ...
Oncogene 19 (1), 51-60, 2000
Revised risk estimation and treatment stratification of low-and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers
A Oberthuer, D Juraeva, B Hero, R Volland, C Sterz, R Schmidt, A Faldum, ...
Clinical Cancer Research 21 (8), 1904-1915, 2015
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20